Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Merck Life Science A/S
A/S
Active
CVR 20830131
Vandtårnsvej 62A, 2860
Søborg
Wholesale of other machinery and equipment
·
NACE 4664
Est. 1998 · 28 years old
24 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of other machinery and equipment
/
Merck Life Science A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
2.2B
1.6B
1.1B
0.5B
0B
2021: 1.0B
1.0B
2021
2022: 1.3B (+24% vs 2021)
1.3B
+24%
2022
2023: 1.4B (+11% vs 2022)
1.4B
+11%
2023
2024: 1.5B (+10% vs 2023)
1.5B
+10%
2024
2025: 1.7B (+14% vs 2024)
1.7B
+14%
2025
EBITDA
DKK millions
130M
97M
65M
32M
0M
2021: 53M
53M
2021
2022: 59M (+11% vs 2021)
59M
+11%
2022
2023: 93M (+58% vs 2022)
93M
+58%
2023
2024: 85M (-9% vs 2023)
85M
-9%
2024
2025: 104M (+22% vs 2024)
104M
+22%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
1.748.797
1.536.249
1.398.642
1.256.087
1.008.596
Staff expenses
-26.873
-23.554
-26.485
-20.686
-16.607
EBITDA
103.685
85.098
93.268
59.439
53.145
Depreciation & amort.
-0
-1.564
-1.564
-1.564
-1.564
EBIT
103.685
83.534
91.705
57.876
51.581
Net financials
-1.897
2.535
2.949
365
-164
Profit before tax
101.788
86.069
94.653
58.240
51.417
Tax
22.295
19.339
21.043
12.239
13.694
Net profit
79.493
66.730
73.610
46.001
37.724
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
322.511
298.297
322.677
233.186
249.887
Equity
226.078
216.586
239.855
166.245
214.691
Long-term debt
31
22
0
0
0
Short-term debt
96.401
81.689
82.634
66.248
34.164
Total debt
96.432
81.711
82.634
66.248
34.164
Financial ratios
5-year trend
EBITDA margin
5,9 %
This company
15,8 %
Market median
This company
Market median
63% below market
2021
2025
Equity ratio
70,1 %
This company
38,2 %
Market median
This company
Market median
84% above market
2021
2025
Return on equity
35,2 %
This company
18,4 %
Market median
This company
Market median
91% above market
2021
2025
Net profit margin
4,5 %
This company
8,1 %
Market median
This company
Market median
44% below market
2021
2025
Asset turnover
5,42×
This company
1,12×
Market median
This company
Market median
384% above market
2021
2025
Debt / equity
0,43×
This company
0,62×
Market median
This company
Market median
31% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Merck Life Science A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
